Last reviewed · How we verify
0.25% Timolol Maleate Gel Forming Solution — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
0.25% Timolol Maleate Gel Forming Solution (0.25% Timolol Maleate Gel Forming Solution) — Kanecia Obie Zimmerman.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 0.25% Timolol Maleate Gel Forming Solution TARGET | 0.25% Timolol Maleate Gel Forming Solution | Kanecia Obie Zimmerman | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 0.25% Timolol Maleate Gel Forming Solution CI watch — RSS
- 0.25% Timolol Maleate Gel Forming Solution CI watch — Atom
- 0.25% Timolol Maleate Gel Forming Solution CI watch — JSON
- 0.25% Timolol Maleate Gel Forming Solution alone — RSS
Cite this brief
Drug Landscape (2026). 0.25% Timolol Maleate Gel Forming Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/0-25-timolol-maleate-gel-forming-solution. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab